Production (Stage)
Core Scientific, Inc.
CORZ
$10.68
-$0.15-1.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.83% | -44.79% | |||
| Total Other Revenue | -15.92% | 17.26% | |||
| Total Revenue | -16.22% | -0.45% | |||
| Cost of Revenue | -16.95% | -5.31% | |||
| Gross Profit | -9.37% | 93.76% | |||
| SG&A Expenses | -6.44% | 1.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 1,227.70% | 290.78% | |||
| Total Operating Expenses | -9.25% | -1.11% | |||
| Operating Income | -7.46% | 2.64% | |||
| Income Before Tax | 319.07% | 41.74% | |||
| Income Tax Expenses | -45.33% | 179.85% | |||
| Earnings from Continuing Operations | 318.68% | 41.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 318.68% | 41.67% | |||
| EBIT | -7.46% | 2.64% | |||
| EBITDA | -68.17% | -13.10% | |||
| EPS Basic | 338.29% | 48.59% | |||
| Normalized Basic EPS | 309.59% | 43.39% | |||
| EPS Diluted | 307.09% | 48.59% | |||
| Normalized Diluted EPS | 281.82% | 43.39% | |||
| Average Basic Shares Outstanding | 2.95% | 4.67% | |||
| Average Diluted Shares Outstanding | 18.67% | 4.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||